Immunitrack’s Platform for Epitope Binding Assays to MHC I and II: NeoScreen™
NeoscreenTM from Immunitrack is a leading platform technology for study of Major Histocompatibility Complex class I and class II (MHCI&II) interaction with epitopes of interest.
NeoScreen™ allows Immunitrack to rapidly screen libraries with thousands of (neo)epitopes. Depending on the desired immune response, our clients can then pick the best candidates for taking forward, for example in therapeutic development projects. Epitopes from viruses, bacteria, but also from biologics, vaccines and cancer, may be presented by MHC class I (for somatic cells) and MHCII (for antigen presenting cells)